These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 32272938)

  • 21. ULK overexpression mitigates motor deficits and neuropathology in mouse models of Machado-Joseph disease.
    Vasconcelos-Ferreira A; Martins IM; Lobo D; Pereira D; Lopes MM; Faro R; Lopes SM; Verbeek D; Schmidt T; Nóbrega C; Pereira de Almeida L
    Mol Ther; 2022 Jan; 30(1):370-387. PubMed ID: 34298131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3/MJD.
    Switonski PM; Szlachcic WJ; Krzyzosiak WJ; Figiel M
    Neurobiol Dis; 2015 Jan; 73():174-88. PubMed ID: 25301414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Caffeine and adenosine A(2A) receptor inactivation decrease striatal neuropathology in a lentiviral-based model of Machado-Joseph disease.
    Gonçalves N; Simões AT; Cunha RA; de Almeida LP
    Ann Neurol; 2013 May; 73(5):655-66. PubMed ID: 23625556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repeated Mesenchymal Stromal Cell Treatment Sustainably Alleviates Machado-Joseph Disease.
    Oliveira Miranda C; Marcelo A; Silva TP; Barata J; Vasconcelos-Ferreira A; Pereira D; Nóbrega C; Duarte S; Barros I; Alves J; Sereno J; Petrella LI; Castelhano J; Paiva VH; Rodrigues-Santos P; Alves V; Nunes-Correia I; Nobre RJ; Gomes C; Castelo-Branco M; Pereira de Almeida L
    Mol Ther; 2018 Sep; 26(9):2131-2151. PubMed ID: 30087083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RNA interference mitigates motor and neuropathological deficits in a cerebellar mouse model of Machado-Joseph disease.
    Nóbrega C; Nascimento-Ferreira I; Onofre I; Albuquerque D; Déglon N; de Almeida LP
    PLoS One; 2014; 9(8):e100086. PubMed ID: 25144231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Novel SCA3 Knock-in Mouse Model Mimics the Human SCA3 Disease Phenotype Including Neuropathological, Behavioral, and Transcriptional Abnormalities Especially in Oligodendrocytes.
    Haas E; Incebacak RD; Hentrich T; Huridou C; Schmidt T; Casadei N; Maringer Y; Bahl C; Zimmermann F; Mills JD; Aronica E; Riess O; Schulze-Hentrich JM; Hübener-Schmid J
    Mol Neurobiol; 2022 Jan; 59(1):495-522. PubMed ID: 34716557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A mutant ataxin-3 putative-cleavage fragment in brains of Machado-Joseph disease patients and transgenic mice is cytotoxic above a critical concentration.
    Goti D; Katzen SM; Mez J; Kurtis N; Kiluk J; Ben-Haïem L; Jenkins NA; Copeland NG; Kakizuka A; Sharp AH; Ross CA; Mouton PR; Colomer V
    J Neurosci; 2004 Nov; 24(45):10266-79. PubMed ID: 15537899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Re-establishing ataxin-2 downregulates translation of mutant ataxin-3 and alleviates Machado-Joseph disease.
    Nóbrega C; Carmo-Silva S; Albuquerque D; Vasconcelos-Ferreira A; Vijayakumar UG; Mendonça L; Hirai H; de Almeida LP
    Brain; 2015 Dec; 138(Pt 12):3537-54. PubMed ID: 26490332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cordycepin activates autophagy through AMPK phosphorylation to reduce abnormalities in Machado-Joseph disease models.
    Marcelo A; Brito F; Carmo-Silva S; Matos CA; Alves-Cruzeiro J; Vasconcelos-Ferreira A; Koppenol R; Mendonça L; de Almeida LP; Nóbrega C
    Hum Mol Genet; 2019 Jan; 28(1):51-63. PubMed ID: 30219871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibroblasts of Machado Joseph Disease patients reveal autophagy impairment.
    Onofre I; Mendonça N; Lopes S; Nobre R; de Melo JB; Carreira IM; Januário C; Gonçalves AF; de Almeida LP
    Sci Rep; 2016 Jun; 6():28220. PubMed ID: 27328712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ibuprofen enhances synaptic function and neural progenitors proliferation markers and improves neuropathology and motor coordination in Machado-Joseph disease models.
    Mendonça LS; Nóbrega C; Tavino S; Brinkhaus M; Matos C; Tomé S; Moreira R; Henriques D; Kaspar BK; Pereira de Almeida L
    Hum Mol Genet; 2019 Nov; 28(22):3691-3703. PubMed ID: 31127937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unravelling Endogenous MicroRNA System Dysfunction as a New Pathophysiological Mechanism in Machado-Joseph Disease.
    Carmona V; Cunha-Santos J; Onofre I; Simões AT; Vijayakumar U; Davidson BL; Pereira de Almeida L
    Mol Ther; 2017 Apr; 25(4):1038-1055. PubMed ID: 28236575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Caloric restriction blocks neuropathology and motor deficits in Machado-Joseph disease mouse models through SIRT1 pathway.
    Cunha-Santos J; Duarte-Neves J; Carmona V; Guarente L; Pereira de Almeida L; Cavadas C
    Nat Commun; 2016 May; 7():11445. PubMed ID: 27165717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective roles of carbonic anhydrase 8 in Machado-Joseph Disease.
    Hsieh M; Hsieh BY; Ma CY; Li YT; Liu CS; Lo CM
    J Neurosci Res; 2019 Oct; 97(10):1278-1297. PubMed ID: 31157458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KPNB1 modulates the Machado-Joseph disease protein ataxin-3 through activation of the mitochondrial protease CLPP.
    Abeditashi M; Weber JJ; Pereira Sena P; Velic A; Kalimeri M; Incebacak Eltemur RD; Schmidt J; Hübener-Schmid J; Hauser S; Macek B; Riess O; Schmidt T
    Cell Mol Life Sci; 2022 Jul; 79(8):401. PubMed ID: 35794401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Motor uncoordination and neuropathology in a transgenic mouse model of Machado-Joseph disease lacking intranuclear inclusions and ataxin-3 cleavage products.
    Silva-Fernandes A; Costa Mdo C; Duarte-Silva S; Oliveira P; Botelho CM; Martins L; Mariz JA; Ferreira T; Ribeiro F; Correia-Neves M; Costa C; Maciel P
    Neurobiol Dis; 2010 Oct; 40(1):163-76. PubMed ID: 20510362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A mutant ataxin-3 fragment results from processing at a site N-terminal to amino acid 190 in brain of Machado-Joseph disease-like transgenic mice.
    Colomer Gould VF; Goti D; Pearce D; Gonzalez GA; Gao H; Bermudez de Leon M; Jenkins NA; Copeland NG; Ross CA; Brown DR
    Neurobiol Dis; 2007 Sep; 27(3):362-9. PubMed ID: 17632007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spermidine treatment: induction of autophagy but also apoptosis?
    Watchon M; Wright AL; Ahel HI; Robinson KJ; Plenderleith SK; Kuriakose A; Yuan KC; Laird AS
    Mol Brain; 2024 Mar; 17(1):15. PubMed ID: 38443995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calpain-1 ablation partially rescues disease-associated hallmarks in models of Machado-Joseph disease.
    Weber JJ; Haas E; Maringer Y; Hauser S; Casadei NLP; Chishti AH; Riess O; Hübener-Schmid J
    Hum Mol Genet; 2020 Apr; 29(6):892-906. PubMed ID: 31960910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Neuropathology of Spinocerebellar Ataxia Type 3/Machado-Joseph Disease.
    Koeppen AH
    Adv Exp Med Biol; 2018; 1049():233-241. PubMed ID: 29427106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.